日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genomic determinants of response and resistance to pirtobrutinib in relapsed/refractory chronic lymphocytic leukemia

复发/难治性慢性淋巴细胞白血病对吡托布替尼的反应和耐药性的基因组决定因素

Brown, Jennifer R; Nguyen, Bastien; Desikan, Sai Prasad; Won, Helen; Tantawy, Shady I; McNeely, Samuel C; Marella, Narasimha; Randeria, Hetal S; Hanson, Lauren M; Parker, Andrew; Botelho, Salomé Calado; Woyach, Jennifer A; Patel, Krish; Tam, Constantine S; Eyre, Toby A; Cheah, Chan Y; Shah, Nirav N; Ghia, Paolo; Jurczak, Wojciech; Balbas, Minna; Nair, Binoj; Abada, Paolo; Wang, Chunxiao; Wang, Denise; Roeker, Lindsey E; Gandhi, Varsha; Wierda, William G

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中枢神经系统受累:欧洲慢性淋巴细胞白血病研究倡议(ERIC)的一项国际回顾性研究

Chatzikonstantinou, Thomas; Mikhaleva, Mariia; Brieghel, Christian; Papangelou, Christina; Minga, Eva; Arrais-Rodrigues, Celso; Besikli-Dimou, Sotiria; Cerutti, Amalia; Doubek, Michael; Enggaard, Lisbeth; Espinet, Blanca; Ferrer-Lores, Blanca; Garcia Vela, Jose Antonio; Gentile, Massimo; Vázquez, Eva Gimeno; Gutwein, Odit; Herishanu, Yair; Jablonowska-Babij, Paula; Jaksic, Ozren; Josefsson, Par; Kalicińska, Elzbieta; Kislova, Maria; Lista, Enrico; Kotsianidis, Ioannis; Marquet, Juan; Martino, Enrica Antonia; McAuley, Ciaran; Mela Osorio, Maria José; Moia, Riccardo; Mosquera, Claudia; Nikitin, Eugene; Pavlovsky, Miguel Arturo; Pfister, Verena; Savaş, Emine Merve; Scarfò, Lydia; Sever, Matjaz; Shvidel, Lev; Simkovic, Martin; Stavroyianni, Niki; Talimtzi, Persefoni; Tranidou, Antigoni; Visentin, Andrea; Vrachiolias, Georgios; Wasik-Szczepanek, Ewa; Wróbel, Tomasz; Yağcı, Münci; Cellini, Alessandro; Chatzidimitriou, Anastasia; Gaidano, Gianluca; Anderson, Mary Ann; Davids, Matthew S; Brown, Jennifer R; Niemann, Carsten U; Stamatopoulos, Kostas; Ghia, Paolo; Ahn, Inhye E; Koren-Michowitz, Maya

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study

Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性边缘区淋巴瘤:BRUIN 1/2期研究

Patel, Krish; Vose, Julie M; Nasta, Sunita D; Brown, Jennifer R; Maddocks, Kami J; Woyach, Jennifer A; Shah, Nirav N; Fakhri, Bita; Tessoulin, Benoit; Ma, Shuo; Jagadeesh, Deepa; Lech-Maranda, Ewa; Coombs, Catherine C; Patel, Manish R; Rhodes, Joanna M; Ujjani, Chaitra; Hoffmann, Marc S; Cheah, Chan Y; Munir, Talha; Lewis, David; Scarfò, Lydia; Eyre, Toby A; Alencar, Alvaro; Cohen, Jonathon B; Zelenetz, Andrew D; Tsai, Donald E; Li, Mei; Bian, Yuanyuan; Abada, Paolo; Balbas, Minna; Zinzani, Pier Luigi

Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies

泽布替尼用于治疗伴有del(17p)和/或TP53 CLL/SLL的患者:临床研究分析

Tam, Constantine S; Anderson, Mary Ann; Šimkovič, Martin; Ghia, Paolo; Flinn, Ian W; Laribi, Kamel; Opat, Stephen; Cull, Gavin; Munir, Talha; Österborg, Anders; Tedeschi, Alessandra; Wang, Megan; Szeto, Andy; Allewelt, Heather; Salmi, Tommi; Li, Jessica; Xu, Linlin; Wu, Kenneth; Vezan, Remus; Shadman, Mazyar; Brown, Jennifer R

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者

Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S

Zanubrutinib Versus Bendamustine and Rituximab in Patients With Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Median 5-Year Follow-Up of SEQUOIA

在初治慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者中,Zanubrutinib 与 Bendamustine 和 Rituximab 的疗效比较:SEQUOIA 研究的中位 5 年随访结果

Shadman, Mazyar; Munir, Talha; Robak, Tadeusz; Brown, Jennifer R; Kahl, Brad S; Ghia, Paolo; Giannopoulos, Krzysztof; Šimkovič, Martin; Österborg, Anders; Laurenti, Luca; Walker, Patricia A; Opat, Stephen S; Ciepluch, Hanna; Greil, Richard; Hanna, Merit; Tani, Monica; Trněný, Marek; Brander, Danielle; Flinn, Ian W; Grosicki, Sebastian; Verner, Emma; Tedeschi, Alessandra; de Guibert, Sophie; Tumyan, Gayane; Laribi, Kamel; García-Marco, José A; Li, Jian-Yong; Tian, Tian; Liu, Yu; Korolkiewicz, Roman; Szeto, Andy; Tam, Constantine S; Jurczak, Wojciech

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition

利用肿瘤微环境:通过调控上皮-间质转化实现靶向癌症治疗

Glaviano, Antonino; Lau, Hannah Si-Hui; Carter, Lukas M; Lee, E Hui Clarissa; Lam, Hiu Yan; Okina, Elena; Tan, Donavan Jia Jie; Tan, Wency; Ang, Hui Li; Carbone, Daniela; Yee, Michelle Yi-Hui; Shanmugam, Muthu K; Huang, Xiao Zi; Sethi, Gautam; Tan, Tuan Zea; Lim, Lina H K; Huang, Ruby Yun-Ju; Ungefroren, Hendrik; Giovannetti, Elisa; Tang, Dean G; Bruno, Tullia C; Luo, Peng; Andersen, Mads Hald; Qian, Bin-Zhi; Ishihara, Jun; Radisky, Derek C; Elias, Salem; Yadav, Saurabh; Kim, Minah; Robert, Caroline; Diana, Patrizia; Schalper, Kurt A; Shi, Tao; Merghoub, Taha; Krebs, Simone; Kusumbe, Anjali P; Davids, Matthew S; Brown, Jennifer R; Kumar, Alan Prem

BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia

BCL-2依赖性是慢性淋巴细胞白血病治疗反应的有利预测指标。

Chong, Stephen Jun Fei; Lu, Junyan; Valentin, Rebecca; Lehmberg, Timothy Z; Eu, Jie Qing; Wang, Jing; Zhu, Fen; Kong, Li Ren; Fernandes, Stacey M; Zhang, Jeremy; Herbaux, Charles; Goh, Boon Cher; Brown, Jennifer R; Niemann, Carsten U; Huber, Wolfgang; Zenz, Thorsten; Davids, Matthew S

Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

伊布替尼联合乌布拉利西治疗复发/难治性慢性淋巴细胞白血病的1/1b期研究的长期结果

Ryan, Christine E; Ren, Yue; Tyekucheva, Svitlana; Arnason, Jon E; Boruchov, Adam M; Jacobson, Caron A; Fisher, David C; Miskin, Hari; Sportelli, Peter; Brown, Jennifer R; Davids, Matthew S